Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 3 April 1998:
Vol. 280. no. 5360, p. 33
DOI: 10.1126/science.280.5360.33
Prev | Table of Contents | Next

Research News

APOPTOSIS:
Caspase Work Points to Possible New Therapies

Marcia Barinaga

Programmed cell death or apoptosis is a normal part of cells' lives, but sometimes cells refuse the order to die, resulting in cancer, or die when they shouldn't, causing neurodegenerative problems or contributing to the brain damage of stroke. Researchers now hope that what they are learning about the caspases, protein-cutting enzymes that play a key role in apoptosis, may help them correct these imbalances. They have found, for example, that tumor cells--but not normal adults cells--contain high levels of an apoptosis-blocking protein that may work by inhibiting the caspases. If researchers could learn to inactivate this protein, cancer cells might be made more susceptible to therapy; there are also indications that caspase inhibitors could prevent the nerve-cell death that occurs in some neurodegenerative conditions.

Read the Full Text

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)